Top Abstract Purchase Related
Home
>
Node
>
Subnode

Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer

Hasengaowa; Kodama, J.; Kusumoto, T.; Shinyo, Y.; Seki, N.; Nakamura, K.; Hongo, A.; Hiramatsu, Y.

European Journal of Gynaecological Oncology 26(4): 403-406

2005

ISSN/ISBN: 0392-2936
PMID: 16122188
Document Number: 594125
Perlecan is a major heparan sulfate proteoglycan (HPSG) of the basement membrane (BM) and binds to various cytokines and growth factors via its heparan sulfate glycosaminoglycan (HS-GAG) chains. The aim of this study was to investigate BM HS-GAG expression in endometrial cancers. We investigated the expression of BM HS-GAG by immunohistochemistry in 109 endometrial cancers and analyzed correlations with various clinicopathological features. The HS-GAG expression index was significantly lower in cases of advanced stage, high-grade, deep myometrial invasion, positive peritoneal cytology, lymph vascular space invasion and lymph node metastasis. There was no association between HS-GAG expression status and patient outcome. Decreased HS-GAG expression of BM is associated with tumor progression, but is not be a useful prognostic factor in patients presenting with endometrial cancer.

Document emailed within 1 workday
Secure & encrypted payments

Nishinaga, M.; Shimada, K. 1994: Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells Rinsho Byori. Japanese Journal of Clinical Pathology 42(4): 340-345
Zieglschmid, V.; Hollmann, C.; Mannel, J.; Albert, W.; Jaeschke-Melli, S.; Eckstein, B.; Hillemann, T.; Greten, T.F.; Gross, E.; Böcher, O. 2007: Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer Anticancer Research 27(4a): 1823-1832
Montone, K.T.; van Belle, P.; Elenitsas, R.; Elder, D.E. 1997: Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(9): 939-944
Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1991: Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin Seminars in Thrombosis and Hemostasis 17(Suppl 1): 60-64
Caulfield, J.P.; Farquhar, M.G. 1978: Loss of anionic sites from the glomerular basement membrane in aminonucleoside nephrosis Laboratory Investigation; a Journal of Technical Methods and Pathology 39(5): 505-512
Robertson, N.P.; Starkey, J.R.; Hamner, S.; Meadows, G.G. 1989: Tumor cell invasion of three-dimensional matrices of defined composition: evidence for a specific role for heparan sulfate in rodent cell lines Cancer Research 49(7): 1816-1823
Bak, M.; Géczi, L.; Institioris, E.; Eid, H.; Bodrogi, I. 1999: The clinical value of mdm-2 (proto-oncogene) expression in testicular cancer, Correlation with tumor progression Orvosi Hetilap 140(33): 1837-1840
Gang, N.F.; Trachtenberg, E.; Allerhand, J.; Kalant, N.; Mautner, W. 1970: Nephrotoxic serum nephritis. 3. Correlation of proteinuria, excretion of the glomerular basement membrane-like protein, and changes in the ultrastructure of the glomerular basement membrane as visualized with lanthanum Laboratory Investigation; a Journal of Technical Methods and Pathology 23(4): 436-441
Mazurek, A.; Kuc, P.; Terlikowski, S.; Laudanski, T. 2006: Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer Neoplasma 53(3): 242-246
Terranova, V.P.; Hujanen, E.S.; Martin, G.R. 1986: Basement membrane and the invasive activity of metastatic tumor cells Journal of the National Cancer Institute 77(2): 311-316
Knoflach, P.; Albini, B.; Weiser, M.M. 1995: Oral mercuric chloride leads to intestinal basement membrane (IBM) immune complex deposition and fecal protein loss Advances in Experimental Medicine and Biology 371b: 1399-1401
Kanczuga-Koda, L.; Koda, M.; Sulkowski, S.; Wincewicz, A.; Zalewski, B.; Sulkowska, M. 2010: Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis In Vivo 24(1): 101-107
Nakamura, T.; Ebihara, I.; Shirato, I.; Tomino, Y.; Koide, H. 1991: Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis Laboratory Investigation; a Journal of Technical Methods and Pathology 64(5): 640-647
Tang, W.W.; Yin, S.; Wittwer, A.J.; Qi, M. 1995: Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis American Journal of Physiology 269(3 Pt 2): F323-F330
Yoon, T.Mi.; Kim, S-Ae.; Lee, D.Hoon.; Lee, J.Kyoo.; Park, Y-Lan.; Lee, K-Hwa.; Chung, I-Joo.; Joo, Y-Eun.; Lim, S.Chul. 2014: Expression of Livin and the inhibition of tumor progression by Livin silencing in laryngohypopharyngeal cancer In Vivo 28(5): 751-759
Shi, B.; Han, R. 1997: 4-acetamidophenyl retinoate (4-APR) inhibits reconstituted basement membrane invasion by tumor cells and its mechanism Zhonghua Zhong Liu Za Zhi 19(3): 196-199
Basta-Jovanovic, G.; Venkataseshan, V.S.; Gil, J.; Kim, D.U.; Dikman, S.H.; Churg, J. 1990: Morphometric analysis of glomerular basement membranes (GBM) in thin basement membrane disease (TBMD) Clinical Nephrology 33(3): 110-114
Maeda, G.; Chiba, T.; Okazaki, M.; Satoh, T.; Taya, Y.; Aoba, T.; Kato, K.; Kawashiri, S.; Imai, K. 2005: Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression International Journal of Oncology 27(6): 1535-1541
Leivo, I.; Laurila, P.; Wahlström, T.; Engvall, E. 1989: Expression of merosin, a tissue-specific basement membrane protein, in the intermediate trophoblast cells of choriocarcinoma and placenta Laboratory Investigation; a Journal of Technical Methods and Pathology 60(6): 783-790
Ljubimov, A.V.; Burgeson, R.E.; Butkowski, R.J.; Michael, A.F.; Sun, T.T.; Kenney, M.C. 1995: Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms Laboratory Investigation; A Journal of Technical Methods and Pathology 72(4): 461-473